bluebird bio, Inc. (BLUE)
bluebird bio, Inc. (BLUE)
$133.66 USD
Updated Jul 16 4:00pm
Add BLUE to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all “A” rated Strong Buy stocks
BLUE News Stream
| Event/Time | News Detail | Start | End | Change | |||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Top Stories View All
The Expansion Continues for Aurora Cannabis (ACB)
Hexo Corp. (HEXO) began trading on the NYSE today, here’s what it means for the stock
Best & Worst Performing Stock Industries for July 16, 2019
Best & Worst Performing Small Cap Stocks for July 16, 2019
Best & Worst Performing Large Cap Stocks for July 16, 2019
View All Top Storiesbluebird bio, Inc. (BLUE) Company Bio
Bluebird Bio is a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic and rare diseases and T cell-based immunotherapies. The company was founded in 1992 and is based in Cambridge, Massachusetts.
BLUE Stock Chart More Charts
BLUE Price/Volume Stats
| Current price | $133.66 |
| Prev. close | $135.75 |
| Day low | $133.20 |
| Day high | $136.85 |
| 50-day MA | $125.82 |
| 200-day MA | $129.50 |
| 52-week high | $181.77 |
| 52-week low | $87.49 |
| Volume | 383,200 |
| Avg. volume | 539,183 |
| Dividend yield | N/A |
| Market Cap | 7.37B |
BLUE Returns
| 1-mo | 13.60% |
| 3-mo | -4.11% |
| 6-mo | 5.66% |
| 1-year | -24.61% |
| 3-year | 191.64% |
| 5-year | 334.53% |
| YTD | 34.74% |
| 2018 | -44.30% |
| 2017 | 188.65% |
| 2016 | -3.92% |
| 2015 | -29.98% |
| 2014 | 337.18% |
Loading social stream, please wait...